MEDICAL SERVICES

EDUCATION

Medical School

  • Yale University School of Medicine , 1992 , New Haven , CT

Internship

Pediatrics
  • Boston Children's Hospital , 1993 , Boston , MA

Residency

Pediatrics
  • Boston Combined Residency Program (BCRP) , 1995 , Boston , MA

Fellowship

Pediatric Hematology-Oncology
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center , 1997 , Boston , MA

CERTIFICATIONS

  • American Board of Pediatrics, Pediatric Hematology and Oncology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Dix DB, Seibel NL, Chi YY, Khanna G, Mullen EA, Geller JI, Kalapurakal JA, Ehrlich PF, Malogolowkin MH, Fernandez CV, Dome JS. Reply to D.M. Green. J Clin Oncol. 2018 Sep 13; JCO1800659. View abstract
  2. Msaouel P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee CH, Carden MA, Genovese G, Linehan WM, Rao P, Merino MJ, Grodman H, Dome JS, Fernandez CV, Geller JI, Apolo AB, Daw NC, Hodges HC, Moxey-Mims M, Wei D, Bottaro DP, Staehler M, Karam JA, Rathmell WK, Tannir NM. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. Clin Genitourin Cancer. 2018 Sep 12. View abstract
  3. Klega K, Imamovic-Tuco A, Ha G, Clapp AN, Meyer S, Ward A, Clinton C, Nag A, Van Allen E, Mullen E, DuBois SG, Janeway K, Meyerson M, Thorner AR, Crompton BD. Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. JCO Precis Oncol. 2018; 2018. View abstract
  4. Cajaiba MM, Dyer LM, Geller JI, Jennings LJ, George D, Kirschmann D, Rohan SM, Cost NG, Khanna G, Mullen EA, Dome JS, Fernandez CV, Perlman EJ. The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 2018 Aug; 124(16):3381-3389. View abstract
  5. Dix DB, Seibel NL, Chi YY, Khanna G, Gratias E, Anderson JR, Mullen EA, Geller JI, Kalapurakal JA, Paulino AC, Perlman EJ, Ehrlich PF, Malogolowkin M, Gastier-Foster JM, Wagner E, Grundy PE, Fernandez CV, Dome JS. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol. 2018 Jun 01; 36(16):1564-1570. View abstract
  6. Fernandez CV, Perlman EJ, Gastier-Foster J, Geller JI, Mullen EA, Ehrlich PF, Dome JS. Reply to B. Zhang et al. J Clin Oncol. 2018 May 10; 36(14):1454-1455. View abstract
  7. Fernandez CV, Mullen EA, Chi YY, Ehrlich PF, Perlman EJ, Kalapurakal JA, Khanna G, Paulino AC, Hamilton TE, Gow KW, Tochner Z, Hoffer FA, Withycombe JS, Shamberger RC, Kim Y, Geller JI, Anderson JR, Grundy PE, Dome JS. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. J Clin Oncol. 2018 Jan 20; 36(3):254-261. View abstract
  8. Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A. Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors. Nat Genet. 2017 09 27; 49(10):1558. View abstract
  9. Ehrlich P, Chi YY, Chintagumpala MM, Hoffer FA, Perlman EJ, Kalapurakal JA, Warwick A, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, Geller JI, Grundy PE, Fernandez CV, Ritchey ML, Dome JS. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group. Ann Surg. 2017 09; 266(3):470-478. View abstract
  10. Sandberg JK, Mullen EA, Cajaiba MM, Smith EA, Servaes S, Perlman EJ, Geller JI, Ehrlich PF, Cost NG, Dome JS, Fernandez CV, Khanna G. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group. Pediatr Radiol. 2017 Nov; 47(12):1615-1621. View abstract
  11. Beckermann KE, Sharma D, Chaturvedi S, Msaouel P, Abboud MR, Allory Y, Bourdeaut F, Calderaro J, de Cubas AA, Derebail VK, Hong AL, Naik RP, Malouf GG, Mullen EA, Reuter VE, Roberts CWM, Walker CL, Wood CG, DeBaun MR, Van Poppel H, Tannir NM, Rathmell WK. Renal Medullary Carcinoma: Establishing Standards in Practice. J Oncol Pract. 2017 Jul; 13(7):414-421. View abstract
  12. Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A. PGBD5 promotes site-specific oncogenic mutations in human tumors. Nat Genet. 2017 Jul; 49(7):1005-1014. View abstract
  13. Fernandez CV, Perlman EJ, Mullen EA, Chi YY, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, Tian J, Geller JI, Grundy PE, Anderson JR, Dome JS, Shamberger RC. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532. Ann Surg. 2017 04; 265(4):835-840. View abstract
  14. Yi JS, Kamihara J, Kesselheim JC, Davies K, van Hoff J, Silverman LB, Mullen EA. Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. Pediatr Blood Cancer. 2017 05; 64(5). View abstract
  15. Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol. 2016 09 10; 34(26):3189-94. View abstract
  16. Ehrlich PF, Hamilton TE, Gow K, Barnhart D, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Perlman EJ, Kalapurakal JA, Khanna G, Dome JS, Geller J, Mullen E. Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2016 11; 63(11):1905-10. View abstract
  17. Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ. Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. Hum Pathol. 2016 Feb; 48:81-7. View abstract
  18. Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. J Clin Oncol. 2015 Sep 20; 33(27):2999-3007. View abstract
  19. Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. Cancer. 2015 Jul 15; 121(14):2457-64. View abstract
  20. Servaes S, Khanna G, Naranjo A, Geller JI, Ehrlich PF, Gow KW, Perlman EJ, Dome JS, Gratias E, Mullen EA. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol. 2015 Feb; 45(2):166-72. View abstract
  21. Ferrer FA, Herbst KW, Fernandez CV, Khanna G, Dome JS, Naranjo A, Mullen EA, Geller JI, Gratias EJ, Shamberger R, Ritchey M, Ehrlich PF. Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement. J Pediatr Urol. 2014 Oct; 10(5):969-73. View abstract
  22. Doros LA, Rossi CT, Yang J, Field A, Williams GM, Messinger Y, Cajaiba MM, Perlman EJ, A Schultz K, Cathro HP, Legallo RD, LaFortune KA, Chikwava KR, Faria P, Geller JI, Dome JS, Mullen EA, Gratias EJ, Dehner LP, Hill DA. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol. 2014 Sep; 27(9):1267-80. View abstract
  23. Hamilton TE, Barnhart D, Gow K, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Gratias E, Geller J, Mullen E, Ehrlich P. Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee study. J Pediatr Surg. 2014 Jan; 49(1):154-8; discussion 158. View abstract
  24. Armon BD, Mullen EA. Uncle Sam and your job options. Considering your next career move? Consider the tax implications. Del Med J. 2013 May; 85(5):147-9. View abstract
  25. Gow KW, Barnhart DC, Hamilton TE, Kandel JJ, Chen MK, Ferrer FA, Price MR, Mullen EA, Geller JI, Gratias EJ, Rosen N, Khanna G, Naranjo A, Ritchey ML, Grundy PE, Dome JS, Ehrlich PF. Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. J Pediatr Surg. 2013 Jan; 48(1):34-8. View abstract
  26. Dome JS, Fernandez CV, Mullen EA, Kalapurakal JA, Geller JI, Huff V, Gratias EJ, Dix DB, Ehrlich PF, Khanna G, Malogolowkin MH, Anderson JR, Naranjo A, Perlman EJ. Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):994-1000. View abstract
  27. Khanna G, Naranjo A, Hoffer F, Mullen E, Geller J, Gratias EJ, Ehrlich PF, Perlman EJ, Rosen N, Grundy P, Dome JS. Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. Radiology. 2013 Feb; 266(2):610-7. View abstract
  28. Fernandez CV, Li N, Mullen EA, Grundy PE, Perman EJ, Shamberger RC, Ehrlich PF, Dome JS. Barriers to the enrollment of children in the Children's Oncology Group study of very low risk Wilms tumor: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2011 Oct; 33(7):521-3. View abstract
  29. Mullen EA, Anderson JR, Steacy KJ, Geller JI, Green DM, Norkool P, Fernandez CV, Khanna G, Malogolowkin MH, Dome J. The impact of surveillance imaging on overall survival in patients with recurrent Wilms tumor: A report from the Children's Oncology Group. J Clin Oncol. 2011 May 20; 29(15_suppl):9536. View abstract
  30. Metzger ML, Stewart CF, Freeman BB, Billups CA, Hoffer FA, Wu J, Coppes MJ, Grant R, Chintagumpala M, Mullen EA, Alvarado C, Daw NC, Dome JS. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. J Clin Oncol. 2007 Jul 20; 25(21):3130-6. View abstract
  31. E A Mullen. Pediatric Oncologic Emergencies. Nathan & Oski's Hematology Textbook of Infancy and Childhood. 2007; In Press. View abstract
  32. Wang Y, Sands LP, Vaurio L, Mullen EA, Leung JM. The effects of postoperative pain and its management on postoperative cognitive dysfunction. Am J Geriatr Psychiatry. 2007 Jan; 15(1):50-9. View abstract
  33. Kolden GG, Chisholm-Stockard SM, Strauman TJ, Tierney SC, Mullen EA, Schneider KL. Universal session-level change processes in an early session of psychotherapy: path models. J Consult Clin Psychol. 2006 Apr; 74(2):327-36. View abstract
  34. EA Mullen. Section Editor, Oncology. Pediatric Hospitalist Textbook, Chiang. 2006. View abstract
  35. EA Mullen. Oncologic Emergencies Chapter. Pediatric Hospitalist Textbook, Chiang. 2006. View abstract
  36. Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006 Apr; 102(4):1267-73. View abstract
  37. Mullen E, Skitka LJ. Exploring the psychological underpinnings of the moral mandate effect: motivated reasoning, group differentiation, or anger? J Pers Soc Psychol. 2006 Apr; 90(4):629-43. View abstract
  38. Mullen EA. Section Editor, Oncology. Pediatric Hospitalist Textbook. 2006. View abstract
  39. B Mueller, M Dinu, R Bryant, E Mullen J Yan, C Brugnara. The Safety of Oral Magnesium Pidolate in Children with Hemoglobin SC Disease. Presented at the 28th Annual Meeting of the National Sickle Cell Disease Program. 2005. View abstract
  40. Jones M, Campbell KA, Duggan C, Young G, Bousvaros A, Higgins L, Mullen E. Multiple micronutrient deficiencies in a child fed an elemental formula. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):602-5. View abstract
  41. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clincial Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Acute Chest. 2001. View abstract
  42. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines on the treatment of patients with Sickle Cell Disease, on the topic of Transfusion. 2001. View abstract
  43. Jones, Monica; Campbell, Katie A.; Duggan, Christopher; Young, Gregory; Bousvaros, Athos; Higgins, Laurie; Mullen, Elizabeth . Multiple Micronutrient Deficiencies in a Child Fed an Elemental Formula. Journal of Pediatric Oncology. 2001; (5):602-605. View abstract
  44. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Pain. 2000. View abstract
  45. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Routine Health Maintainence and Priapism. 2000. View abstract
  46. E. Mullen, Lead Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Fever. 2000. View abstract
  47. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Splenic Sequestration. 2000. View abstract
  48. E. Mullen, Co-Author, and the Children's Hospital Clinical Practice Guideline Committee. . Clinical Practice Guidelines for the treatment of Pain in Sickle Cell Disease. 2000. View abstract
  49. E. Mullen, Lead Author, and the Children's Hospital Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of Fever in Sickle Cell Disease. 2000. View abstract
  50. E. Mullen, Co-Author, and the Children's Hospital Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of Fever and Neutropenia. 2000. View abstract
  51. Szabo S, Pihan G, Raza A, Mullen EA, Hauschka PV. Multiple Mechanisms of Cell Injury in the Gastric Mucosa. Federal Proceedings. 1991; 46:1152. View abstract
  52. Mullen EA. Biochemical Characterization of a Boving Corneal Angiogenesis Inhibitor. 1991. View abstract
  53. Mullen EA, McKee MD, Hauschka PV. . Fluorogenic Assay of Proteinase Activity in Developing Rat Enamel. Journal of Dental Research. 1989; 68:239. View abstract
  54. Hauschka PV, Mullen EA, Hintsch G, Jazwinski S. Abundant Occurrence of Gamma-Carboxyglutamic Acid-Containing Peptides in the Gastropod Family. Current Advances in Vitamin K Research. Ed. John Suttie. 1988. View abstract
  55. Mullen, EA. An examination of the Vitamin K Cycle: Phenytoin Interference in K-dependent Carboxylase Activity. 1985. View abstract